Almenoff June Sherie
- SEC CIK
- 0001492647
In the past year, 1 open-market purchase filing worth $15.0K and no sales.
Current role at each company
- ATNM Actinium Pharmaceuticals, Inc.Directoras of Sep 4, 2026
- TENX Tenax Therapeutics, Inc.Directoras of Jan 13, 2026
- AVTX Avalo Therapeutics, Inc.Directoras of Jun 18, 2025
- BCLI Brainstorm Cell Therapeutics Inc.Directoras of Dec 17, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $15.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$15.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Almenoff June Sherie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TENX Tenax Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing) | Nov 17-18 | 3 days | Almenoff June SherieDirector | PPurchase | +1.99K | $7.50 | +$15.0K | New position1.99K after | Amended2 lots |
AVTX Avalo Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 (view filing) | Nov 12-13 | 2 days | Almenoff June SherieDirector | PPurchase | +1.00K | $12.75 | +$12.8K | New position1.00K after | 2 lots |